Ultra scale-down studies of the effect of shear on cell quality; Processing of a human cell line for cancer vaccine therapy

Biotechnology Progress

Volumn 25, Issue 5, 2009, Pages 1448-1458

  McCoy, Ryan ^a   Hoare, Mike ^a   Ward, Stephen ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cell surface markers; Hydrodynamic shear; Membrane integrity; Ultra scale down; Whole cell therapy

Indexed keywords

CELL SURFACE MARKERS; HYDRODYNAMIC SHEAR; MEMBRANE INTEGRITY; ULTRA SCALE-DOWN; WHOLE CELL THERAPY;

CELL CULTURE; DISEASES; FLUID DYNAMICS; HYDRODYNAMICS; QUALITY ASSURANCE; SHEAR DEFORMATION; VACCINES;

CELL MEMBRANES;

CANCER VACCINE;

ARTICLE; BIOLOGICAL THERAPY; CELL LINE; CELL MEMBRANE; CELL SIZE; CYTOLOGY; FLOW CYTOMETRY; HUMAN; METABOLISM; METHODOLOGY; SHEAR STRENGTH;

CANCER VACCINES; CELL LINE; CELL MEMBRANE; CELL SIZE; FLOW CYTOMETRY; HUMANS; SHEAR STRENGTH; TISSUE THERAPY;

EID: 70350164380     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.229     Document Type: Article

References (47)

1. Eaton JD, Perry MJA, Nicholson S, Guckian M, Russell N, Whelan M, Kirby RS. Allogeneic whole cell vaccine: a phase I/II study in men with hormone refractory prostate cancer. Br J Urol Int. 2002;89:19-26.
2. Michael A, Ball G, Quatan N, Wushishi F, Russell N, Whelan J, Chakraborty P, Leader D, Whelan M, Pandha H. Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate cancer and correlation with immunologic variables. Clin Cancer Res. 2005;11:4469-4478.
3. Harris JE, Ryan L, Hoover HC Jr, Stuart RK, Oken MM, Benson AB III, Mansour E, Haller DG, Manola J, Hanna MG Jr. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: eastern Cooperative Oncology Group Study E5283. J Clin Oncol. 2000;18: 148-157.
4. Jocham D, Richter A, Hoffmann L, Iwig K, Fahlenkamp D, Zakrzewski G, Schmitt E, Dannenberg T, Lehmacher W, von Wietersheim J, Doehn C. Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal cell carcinoma after radical nephrectomy: phase III, randomised control trial. Lancet 2004;363:594-599.
5. Ochsenbein AF, Klenerman P, Karrer U, Ludewig B, Pericin M, Hengartner H, Zinkernagel RM. Immune surveillance against a solid tumour fails because of immunological ignorance. Proc Natl Acad Sci. 1999;96:2233-2238.
6. Miyake M, Nakano K, Ieki Y, Adachi M, Hueng C-L, Itoi S, Koh T, Taki T. Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res. 1995;55:4127-4131.
7. Sho M, Adachi M, Taki T, Hashida H, Konishi T, Huang C, Ikeda N, Nakajima H, Hisanaga M, Nakano H, Miyake M. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer. 1998;79:509-516.
8. Miyake M, Adachi M, Huang C, Higashiyama M, Kodama K, Taki T. A novel molecular staging protocol for non small cell lung cancer. Oncogene. 1999;18:2397-2404.
9. Uchida S, Shimada Y, Watanbe G, Gang Li Z, Hong T, Miyake M, Imamura M. Motility-related protein (MRP-1/CD9) and KAI/CD82 expression is inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer. 1999;79:1168-1173.
10. Gutierrez-Lopez MD, Ovalle N, Yanez-Mo M, Sanchez-Sanchez N, Rubinstein E, Olmo E, Lizarbe MA, Sanchez-Madrid F, Cabanas C. A functionally relevant conformational epitope on the CD9 tetraspanin depends on the association with activated B1 integrin. J Biol Chem. 2003;278:208-218.
11. Rubinstein E, Le Naour F, Lagaudriere-Gesbert C, Billard M, Conjeaud H, Boucheix C. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLADR and VLA integrins. Eur J Immunol. 1996;26:2657-2665.
12. Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochemie. 2005;87:361-368.
13. Kirk P, Wilson MC, Heddle C, Brown MH, Barclay AN, Halestrap AP. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. Eur Mol Biol Organ. 2000;19:3896-3904.
14. Berditchevski F, Chang S, Bodorova J, Hemler ME. Generation of monoclonal antibodies to integrin associated proteins J Biol Chem. 1997;272:29174-29180.
15. Pushkarsky T, Yurchenko V, Vanpouille C, Brichacek B, Vaisman I, Hatakeyama S, Nakayama KI, Sherry B, Bukrinsky MI. Cell surface expression of CD147/EMMPRIN is regulated by cyclophilin 60. J Biol Chem. 2005;280:27866-27871.
16. Tang W, Chang SB, Hemler ME. Links between CD147 function, glycosylation, and caveolin-1. Mol Biol cell. 2004;15:4043-4050.
17. Liu AY. Differential expression of cell surface molecules in prostate cancer cells. Cancer Res. 2000;60:3429-3434.
18. Blades RA, Keating PJ, McWilliam LJ, George NJR, Stern PL. Loss of HLA class I expression in prostate cancer: implications for immunotherapy. Urology 1995;46:681-687.
19. Cabrera T, Lara E, Romero JM, Maleno I, Real LM, Ruiz-Cabello F, Valero P, Camacho FM, Garrido F. HLA class I expression in metastatic melanoma correlates with tumour development during autologous vaccination. Cancer Immunol Immunother. 2007;56:709-717.
20. International conference on harmonisation (ICH) of technical requirements for registration of pharmaceuticals for human use. Guideline Q8, Pharmaceutical Development. 2005.
21. Moreira JL, Alves PM. Hydrodynamic effects on BHK cells grown as suspended natural aggregates. Biotechnol Bioeng. 1995;46:351-360.
22. Keane JT, Ryan D, Gray PP. Effect of shear stress on expression of a recombinant protein by chinese hamster ovary cells. Biotechnol Bioeng. 2003;81:211-220.
23. Mardikar SH, Niranjan K. Observations on the shear damage to different animal cells in a concentric cylinder viscometer. Biotechnol Bioeng. 2000;68:697-704.
24. Zoro BJH, Owen S, Drake RAL, Hoare M. The impact of process stress on suspended anchorage-dependent mammalian cells as an indicator of likely challenges for regenerative medicines. Biotechnol Bioeng. 2008;99:468-474.
25. Ma N, Koelling K, Chalmers JJ. Fabrication and use of a transient contractional flow device to quantify the sensitivity of mammalian and insect cells to hydrodynamic forces. Biotechnol Bioeng. 2002;80:428-437.
26. Yim SSS, Ayazi Shamlou P. The engineering effects of fluids flow on freely suspended biological macro-materials and macromolecules. Adv Biochem Eng Biotechnol. 2000;67:83-122.
27. Mollet M, Ma N, Zhao Y, Brodkey R, Taticek R, Chalmers JJ. Bioprocess equipment: characterization of energy dissipation rate and its potential to damage cells. Biotechnol Prog. 2004;20:1437-1448.
28. Boychyn M, Yim SSS, Ayazi Shamlou P, Bulmer M, More J, Hoare M. Characterization of flow intensity in continuous centrifuges for the development of laboratory mimics. Chem Eng Sci. 2001;56:4759-4770.
29. Hutchinson N, Bingham N, Murrell N, Farid S, Hoare M. Shear stress analysis of mammalian cell suspensions for prediction of industrial centrifugation and its verification. Biotechnol Bioeng. 2006;95:483-493.
30. Levy MS, Collins IJ, Yim SSS, Ward JN, Titchner-Hooker N, Ayazi Shamlou P, Dunnill P. Effect of shear on plasmid DNA in solution. Bioprocess Eng. 1999;20:7-13.
31. Neal G, Christie J, Keshavarz-Moore E, Ayazi Shamlou P. Ultra scale-down approach for the recovery of ovine polycolonal immunoglobulins used in the manufacture of snake venom specific Fab fragment. Biotechnol Bioeng. 2003;81:149-157.
32. Dixon WJ. Processing data for outliers. Biometrics. 1953;9:74-89.
33. Tholudur A, Giron L, Alam K, Thomas T, Garr E, Weatherly G, Kuloweic K, Quick M, Shepard S. Comparing automated and manual cell counts for cell culture applications. Bioprocess Int. 2006;4:28-38.
34. McNeil PL, Steinhardt RA. Loss, restoration and maintenance of plasma membrane integrity. J Cell Biol. 1997;137:1-4.
35. McNeil PL, Vogel SS, Miyake K, Terasaki M. Patching plasma membrane disruption with cytoplasmic membrane. J Cell Sci. 2000;113:1891-1902.
36. Steinhardt RA. The mechanisms of cell membrane repair. Ann N Y Acad Sci. 2005;1066:152-165.
37. Terasaki M, Miyake K, McNeil PL. Large plasma membrane disruptions are rapidly resealed by Ca2+ dependent vesicle-vesicle fusion events. J Cell Biol. 1997;139:63-74.
38. Al-Rubeai M, Emery AN, Chalder S, Goldman MH. A flow cytometric study of hydrodynamic damage to mammalian cells. J Biotechnol. 1993;31:161-177.
39. Carswell KS, Papoutsakis ET. Culture of human T cells in stirred bioreactors for cellular immunotherapy applications: shear, proliferation and the IL-2 receptor. Biotechnol Bioeng. 2000;68:328-338.
40. McDowell CL, Papoutsakis ET. Increased agitation intensity increases CD13 receptor surface content and mRNA levels, and alters the metabolism of HL60 cells cultured in stirred tank bioreactors. Biotechnol Bioeng. 1998;60:239-250.
41. McDowell CL, Papoutsakis ET. Serum increases the CD13 receptor expression, reduces the transduction of fluid-mechanical forces, and alters the metabolism of HL60 cells cultured in agitated bioreactors. Biotechnol Bioeng. 1998;60:259-268.
42. Petricciani J, Egan W, Vicari G, Furesz J, Schild G. Potency assays for therapeutic live whole cell cancer vaccines. Biologicals. 2007;35:107-113.
43. Kurai J, Chikumi H, Hashimoto K, Yamaguchi K, Yamasaki A, Sako T, Touge H, Makino H, Takata M, Miyata M, Nakamoto M, Burioka N, Shimizu E. Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines. Clin Cancer Res. 2007;13:1552-1561.
44. Lustig HJ, Bianco C. Antibody-mediated cell cytotoxicity in a defined system: regulation by antigen, antibody, and complement. J Immunol. 1976;116:253-260.
45. Niwa R, Sakurada M, Kobayashi Y, Uehara A, Matsushima K, Ueda R, Nakamura K, Shitara K. Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density. Clin Cancer Res. 2005;11:2327-2336.
46. Diepolder HM, Gruener NH, Gerlach JT, Jung M-C, Wierenga EA, Pape GR. Different levels of T-cell receptor triggering induce distinct functions in Hepatitis B and Hepatitis C virus-specific human CD4+ T-Cell Clones. J Virol. 2001;75:7803-7810.
47. O'Connell J, O'Sullivan G, Collins J, Shanahan F. The Fas counterattack: Fas-mediated t-cell killing by colon cancer cells expressing Fas ligand. J Exp Med. 1996;184:1075-1082.